Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Hepatitis B and hepatitis C.

Stephen A Geller1

  • 1Department of Pathology and Laboratory Medicine, Cedars-Sinai Medical Center, 8700 Beverly Boulevard, Los Angeles, CA 90048, USA. geller@cshs.org

Clinics in Liver Disease
|July 19, 2002
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Carcinoid heart disease.

Autopsy & case reports·2019
Same author

Churg-Strauss Syndrome: a syndrome described on clinical observation and autopsy findings.

Autopsy & case reports·2019
Same author

Asbestos-related pleural disease.

Autopsy & case reports·2019
Same author

TO THE EDITOR.

Autopsy & case reports·2019
Same author

Esophageal involvement in progressive systemic sclerosis.

Autopsy & case reports·2019
Same author

Autoimmune hepatitis: Histopathology.

Clinical liver disease·2019
Same journal

Metabolic Dysfunction-Associated Steatohepatitis: From Fibrosis-Based Risk Stratification to Emerging Therapeutic Strategies.

Clinics in liver disease·2026
Same journal

Metabolic Dysfunction-Associated Steatotic Liver Disease and Viral Hepatitis.

Clinics in liver disease·2026
Same journal

Metabolic Dysfunction Associated Steatohepatitis (MASH) in Oceania, Central America, and the Caribbean.

Clinics in liver disease·2026
Same journal

Metabolic Dysfunction-Associated Steatotic Liver Disease in Latin America.

Clinics in liver disease·2026
Same journal

Metabolic Dysfunction-Associated Steatotic Liver Disease in Africa: From Burden to Action.

Clinics in liver disease·2026
Same journal

Metabolic Dysfunction-Associated Steatotic Liver Disease in Asia: Epidemiology, Clinical Features, and Management.

Clinics in liver disease·2026
See all related articles

Hepatitis B (HBV) and Hepatitis C (HCV) are distinct viral infections with similar clinical outcomes. Both HBV and HCV increase the risk of liver cancer and recurrence after transplantation.

Area of Science:

  • Hepatology
  • Virology
  • Immunology

Background:

  • Hepatitis B virus (HBV) and Hepatitis C virus (HCV) are major global infectious hepatitides.
  • While distinct in epidemiology and molecular biology, they share clinical and histopathological similarities in acute and chronic stages.
  • HBV is not directly cytopathic; hepatitis results from the immune response to the virus.

Purpose of the Study:

  • To differentiate the characteristics of Hepatitis B and C.
  • To highlight similarities in clinical manifestations and disease progression.
  • To discuss implications for treatment and prognosis, including cancer risk and post-transplant outcomes.

Main Methods:

  • Comparative analysis of HBV and HCV epidemiology and molecular biology.
  • Review of clinical manifestations and histopathological findings in acute and chronic stages.

Related Experiment Videos

  • Examination of viral pathogenesis, including immune response and quasispecies evolution in HCV.

    • Main Results:

    • HBV infection can lead to co-infection or superinfection with Hepatitis D virus (HDV).
    • HCV exhibits significant genetic heterogeneity with multiple genotypes and subtypes, circulating as quasispecies.
    • Both HBV and HCV infections recur in transplanted livers and significantly elevate the risk of hepatocellular carcinoma.

    Conclusions:

    • Hepatitis B and C, despite differences, pose significant long-term health risks, including liver cancer.
    • Understanding viral heterogeneity and immune responses is crucial for managing these infections.
    • Recurrence post-transplantation and oncogenic potential underscore the severity of chronic HBV and HCV.